AdvisorShares Pure US Cannabis +$0.63 +8.8% Today
1D 1W 1M 3M 1Y 5Y
0 % Dividend Yield
This list is based on the watchlists of people on Stock Events who follow MSOS. It's not an investment recommendation.
This list is an analysis based on recent market events. It's not an investment recommendation.
Amplify Alternative Harvest
MJ
Mkt Cap 0
ETFMG Alternative Harvest ETF focuses on global cannabis companies, directly competing in the cannabis ETF space with MSOS which targets US companies. AdvisorShares Pure Cannabis
YOLO
Mkt Cap 0
AdvisorShares Pure Cannabis ETF is another cannabis-focused ETF, offering direct competition by investing in both US and global cannabis companies. Amplify Seymour Cannabis
CNBS
Mkt Cap 0
Amplify Seymour Cannabis ETF invests in the global cannabis industry, including US markets, making it a competitor by targeting a similar investment theme. Cambria Cannabis
TOKE
Mkt Cap 0
Cambria Cannabis ETF invests in the global cannabis industry, competing with MSOS by targeting a mix of US and international cannabis companies. Amplify U.S. Alternative Harvest
MJUS
Mkt Cap 0
Global X US Cannabis ETF specifically targets the US cannabis market, making it a direct competitor to MSOS which also focuses on US cannabis companies. AdvisorShares MSOS 2x Daily
MSOX
Mkt Cap 0
AdvisorShares Pure US Cannabis ETF is a smaller, more focused version of MSOS, directly competing within the same fund family for investors interested in the US cannabis sector.
AdvisorShares Vice ETF, while broader, includes cannabis among other vice industries, indirectly competing with MSOS by offering exposure to the cannabis sector. CNBX Pharmaceuticals
CNBX
Mkt Cap 311,114
Cannabis Growth ETF by Capital Link focuses on global cannabis companies, including those in the US, providing indirect competition by targeting the broader cannabis market. Miscellaneous
Investment Trusts/Mutual Funds
The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from the marijuana and hemp business in the United States and in derivatives that have economic characteristics similar to such securities. It will concentrate at least 25% of its investments in the pharmaceuticals, biotechnology & life sciences industry group within the health care sector. The fund is non-diversified.
Show more...